Healthcare & Medical Devices

Artificial Discs market to witness a major push via increasing demand for minimally invasive surgeries: A CAGR of 21% to be recorded during 2016-2024

Posted on Updated on

Technological breakthroughs coupled with rise in research activities for treating degenerative disc ailments will push artificial discs market size. In addition to this, reduction in re-operation costs related to artificial discs will further push the industry trends. As per Global Market Insights, Inc., “Artificial Discs Industry value is projected to hit USD 4.5 billion by 2024.” High occurrence of disc degenerative ailments along with the rise in disc surgeries is anticipated to influence business expansion. Furthermore, the growing demand for minimally invasive surgeries is another strong factor expected to fuel the product demand over the years to come.

Germany Artificial Disc Market Size, By Type (USD million)
Germany Artificial Disc Market Size, By Type (USD million) 

Cervical artificial discs and Lumbar artificial discs are the two major types of artificial discs. Cervical artificial discs, which accounted for 65% of artificial discs industry share in 2015, will witness a high surge over the years to come. Increase in disc operations along with easy availability of cervical artificial discs will favorably impact the business. Lumbar disc replacement is highly popular treatment alternative among the patients suffering from severe back pain problems. Lumbar artificial discs market, having collected USD 240 million in 2015, is expected to witness high surge over the coming seven years, driven by its extensive demand across developed countries such as the U.S.

Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/1183

Below are the geographical trends influencing global artificial discs market over 2016-2024:

  • U.S. artificial discs market, estimated at USD 360 million in 2015, is expected to exceed USD 2 billion by 2024. Beneficial compensation policies, high investments in the healthcare sector, and rise in per capita income are few of the key factors projected to drive the revenue.
  • Improved healthcare facilities and rising demand for advanced products is expected to propel Japan artificial discs industry size over the coming timeframe, having contributed over 25% of the overall revenue in 2015.
  • Low cost of disc replacement along with high investments across the healthcare sector is anticipated to drive Germany market revenue over the next few years.
  • China artificial discs industry is projected to grow at a rate of 24% over the coming period of 2016-2024, driven by economic development, inexpensive surgeries, and rapidly expanding medical tourism sector.
  • UK, which accounted for 22% of Europe industry share in terms of revenue, is projected to register an annual growth rate of 19% over the coming seven years. Rise in purchasing capacity, increasing aging population base, and enhanced healthcare infrastructure facilities are expected to drive the regional growth.
  • India artificial discs market is also expected to grow considerably over the coming timeframe, owing to high occurrence of degenerative disc disorders in the region.

Market players will try to increase their revenue through product differentiation, technological innovation, product benchmarking, joint ventures, and strategic collaborations.  Key industry participants include Zimmer-Biomet Company, Depuy Synthes Spine Incorporation, Medtronic Company, Synthes Holding AG, Stryker Corporation, LDS Spine USA, Globus Medical Incorporation, Spinekinetics, NuVasive Incorporation, and Aesculap Implant Systems LLC.

Author Name : Dhananjay Punekar

CTMS Market Outlook: Pharmaceuticals & Biopharmaceuticals industry to dominate the application landscape

Posted on

Rapid economic progress coupled with favorable government regulations for drug approvals will push CTMS market size in emerging economies. High investments in clinical research activities are expected to boost the demand for clinical trial management systems (CTMS) across pharmaceuticals & biopharmaceuticals firms, clinical research organizations, and healthcare sectors. According to Global Market Insights, Inc., “Clinical Trial Management System Market size is projected to hit USD 2 billion by 2024.”In addition, rising occurrence of chronic ailments plus the increasing scope of clinical trials outsourcing is forecast to promote the business growth over the coming seven years.

Europe Clinical Trial Management System Market share, by component, 2012-2024 (USD Million)
Europe Clinical Trial Management System Market share, by component, 2012-2024 (USD Million)

CTMS market is segmented into site based clinical trial management system and enterprise based clinical trial management system. Enterprise based industry, which accounted for more than 70% of the total revenue in 2015, is anticipated to grow considerably over the coming timeframe, driven by its ability to provide specialized services. Site based CTMS is projected to contribute considerably towards the global industry share over the coming seven years.

Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/1155

Pharmaceuticals & Biopharmaceuticals application, which dominated the end-use application landscape in 2015, is forecast to hit USD 1.4 billion by 2024. Tremendous efforts by market players to manufacture new medicines for treating chronic ailments is expected to boost the revenue. CTMS industry size in clinical research organizations is expected to grow at a rate of 14% over 2016-2024, driven by rise in clinical trial outsourcing activities along with high investments in R&D for clinical research business.

Regional highlights of Clinical Trial Management System Market over 2016-2024 are given below:

  • China CTMS industry revenue is forecast to produce more than USD 270 million by 2024. Government initiatives to establish research centers along with high spending on research activities across pharmaceuticals, life sciences, and clinical research sectors will drive regional growth.
  • Beneficial regulations such as allocation of funds for NIH, NCI, and FDA to carry out intense research and develop new healthcare solutions will propel U.S. clinical trial management system market value over the next few years.
  • Brazil CTMS industry is forecast to cross USD 55 million by 2024, driven by new breakthroughs in clinical research, growing popularity of biomedical equipment, and enhanced use of modern healthcare systems.
  • Government rules supporting clinical research are expected to boost CTMS market expansion in Germany over the years to come. Germany CTMS industry revenue is forecast to hit USD 180 million by 2024.
  • India clinical trial management system market value, which was estimated at USD 50 million in 2015, is anticipated to witness a remarkable growth over the coming years. Technological advancements in healthcare coupled with increasing investment in clinical research activities is projected to spur the regional revenue.

Key industry players include eClinForce Incorporation, MedNet Solutions Incorporation, Forte Research Systems Incorporation, Medidata solutions, Bio-Optronics Incorporation, PAREXEL International Corporation, Merge Healthcare Incorporation, VEEVA Systems, Oracle Corporation, and BioClinica Company.

Author Name :Dhananjay Punekar

Sleep apnea devices market outlook: U.S. to witness tremendous product demand

Posted on Updated on

Ongoing medical advancements and increasing awareness regarding the severity of sleep apnea is expected to be the vital factor driving sleep apnea devices market. Increasing lifestyle induced diseases such as obesity and cardiovascular are giving rise to growing prevalence of sleep apnea. A study suggests that over 50% of the global adult population habitually snore, which leads to growth in the rate of obstructive sleep apnea (OSA). As per American Sleep Association, more than 25 million adults in US are diagnosed with OSA. This data proves that there is a massive rise in the incidence of sleep and respiratory disorders, which will lead to significant usage of these devices. Moreover, favorable reimbursement schemes and awareness regarding adoption of these devices is likely to accelerate sleep apnea devices industry trends. As per Global Market Insights, Inc., “Sleep Apnea Devices Market  size is estimated to register an annual growth rate of 7% over the period of 2016-2023.”

Germany sleep apnea devices market size, by product, 2012-2023 (USD Million)
Germany sleep apnea devices market size, by product, 2012-2023 (USD Million)

Sleep apnea devices market is at a developing stage and will see a profitable future with rapidly growing attention towards sleep related disorders. The sleep apnea devices market can be bifurcated into airway clearance system, positive airway pressure, oral appliances, adaptive servo-ventilation, and oxygen device in terms of products. The oral appliances segment is estimated to surpass USD 1 billion by 2023. The flexibility in usage of this device and its generous recommendation to large patient pool is generating lucrative growth prospects in sleep apnea devices market. Moreover, with rising demand for easy-to-use miniature products, positive airway pressure (PAP) devices have witnessed a remarkable surge. This product segment is foreseen to attain a Y-O-Y growth of 10.4%, hitting the track record of being the highest revenue generating therapeutic device in 2015.

Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/489

A large pool of untapped opportunities in the emerging nations will provide sleep apnea devices industry with rewarding grounds over the years to come. Along with this, attention towards serious implication of this disorder on human health and promising reimbursement scenario will fuel the market growth.

Considering the regional outlook, below are the key highlights of sleep apnea devices market dynamics over 2016-2023

  • China sleep apnea devices market is expected to register to a CAGR of 11% from 2016-2023. Increasing incidence of OSA coupled with the rising geriatric population will ignite the regional growth.
  • Japan market, contributing more than 44% of the total regional revenue in 2015, is projected to witness heavy gains in the coming six years. Rising healthcare expenditure and the presence of the huge patient pool is likely to drive the demand for sleep apnea industry.
  • U.S. sleep apnea devices industry is projected to register a CAGR of 7.5% over the span of 2016-2023. The regional growth can be attributed to favorable Medicare policies and deployment of advanced products in the region.
  • UK sleep apnea devices industry is set to grow at a CAGR of 7% over 2016-2023. Favorable government initiatives in this regard will surge the industry growth.
  • Brazil and Germany sleep apnea industry is also anticipated to witness a momentous growth, owing to rising patien awareness levels.

Market players will focus more on product innovation and invest heavily in research to come up with novel products. Prominent companies operating in sleep apnea devices market include ResMed, Carefusion, Cadwell Laboratories, Philips Respironics, Braebon Medical, and Compumedics.

Author Name :Ojaswita Kutepatil

Bench top dental autoclave market outlook: Rising oral health awareness to elevate industry growth over 2016-2023

Posted on Updated on

Rising occurrence of dental problems coupled with growing awareness about sterilization will push Bench top dental autoclave market growth over the coming years. As per CDC report, in 2012, nearly 61% of adults and 62% of old population consulted dentists to perform dental procedures like dental fillings, dental crowns, periodontal therapy, root canals, and maxillofacial procedures. According to Global Market Insights, Inc., study “Bench top dental autoclave market revenue is projected to hit USD 78.7 million by 2023.” Favorable government policies encouraging sterilization to lessen infection acquired at hospitals along with rising healthcare spending will propel the industry trends over the next few years. Growing oral cancer cases, owing to enhanced tobacco as well as alcohol consumption across emerging economies is also projected to drive the business growth.

Europe Bench-top Dental Autoclaves Market size, by Product, 2012 – 2023 (USD Million)

Europe Bench-top Dental Autoclaves Market size, by Product, 2012 - 2023 (USD Million)

Moreover, intense efforts made by the government to promote the use of dental instruments and consumables is projected to escalate bench-top dental autoclaves industry expansion in the near future. For instance, “The Comprehensive Dental Reform Act of 2012” of the U.S. has favorably impacted dental equipment and consumables sector, further enhancing Bench top dental autoclave market development. Favorable compensation policies related to dental coverage along with promotion of oral healthcare campaigns across healthcare centers and schools is expected to drive the growth.

Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/513

Automatic, Pre-& Post vacuum, and Semi-Automatic dental autoclaves are few of the major bench-top dental autoclaves products. Pre & Post vacuum dental autoclaves, which accounted nearly 43% of global Bench top dental autoclave market share in 2015, is anticipated to grow substantially in the years to come. Its rising demand across dental clinics along with cost-effectiveness will spur the product demand.  Automatic bench-top dental autoclaves industry is projected to record an annual growth rate of 7.1% over the coming timeframe, driven by rising automation trends in dentistry to achieve quick & accurate outcomes without human interference.

Geographical trends pertaining to Bench top dental autoclave market over 2016-2023 are as below:

    • Europe bench-top dental autoclaves industry size, estimated at USD 16.4 million in 2015, is anticipated to hit USD 24.8 million by 2023. High incidences of oral ailments such as pyorrhea amongst the aging population are anticipated to boost the regional growth over the years to come.
    • Increasing awareness about oral health coupled with high occurrence of oral diseases is forecast to stimulate bench-top dental autoclaves business expansion in North America. U.S. Bench top dental autoclave market size, which accounted for more than 80% of the overall revenue in 2015, is predicted to drive the regional revenue.
    • Asia Pacific bench-top dental autoclaves industry is forecast to make substantial gains of 7.4% over 2016-2023, driven by growing geriatric population base along with large unmet dental requirements. China, Japan, India, South Korea, and Indonesia are projected to be the major regional growth drivers.

Market players will try to retain their industry position and enhance their revenue by implementing business growth strategies such as strategic alliances, product development, technological innovation, product differentiation, and mergers & acquisitions. Key industry participants include Melag, Tattnauer, Midmark Corporation, W&H Dentalwerk International, Fona Dental, and Antonia Matachana S.A.

Author Name :Dhananjay Punekar

Neurostimulation Devices Market Outlook: China to witness the highest growth rate over 2016-2023

Posted on Updated on

Rising incidences of neurological disorders among the geriatric population will influence neurostimulation devices industry growth. In addition, increasing demands for suitable, cost-effective treatment options, high-tech healthcare facilities, and technologically-driven infrastructure will drive product demand. According to Global Market Insights, Inc., “Neurostimulation Devices Market is predicted to observe a CAGR of more than 14% over 2016-2023.”
Federal guidelines and lack of skilled professionals in the healthcare fraternity may hamper industry growth. However, global incidences of conditions such as epilepsy, migraine, depression, and other neurological ailments are on a constant rise, driving the requirement for positive therapeutic effects of neuro-stimulators.

Germany Neurostimulation Devices Market size, by product, 2012-2023 (USD Million)

Germany Neurostimulation Devices Market size, by product, 2012-2023 (USD Million)

Neurostimulation Devices find applications in the treatment of Parkinson’s Disease, Epilepsy Pain Management, Essential Tremor, Urinary and Fecal Incontinence, Gastroparesis Depression, and Dystonia.

Neurostimulation devices market size for pain management will register a revenue of more than USD 9 billion by 2023 and is expected to grow at a healthy rate owing to the high prevalence of chronic disorders.

Get a Sample Copy of this Report @https://www.gminsights.com/request-sample/detail/436

Therapeutic applications for Parkinson’s disease will increase at a high rate over 2016-2023 driven by the increasing elderly population and limited treatment options.

The epilepsy application segment is predicted to exceed USD 600 million by 2023 driven by product efficiency and less availability of suitable treatment.

Tremors are commonly faced by people above the age of 40 and can be treated using implantable deep brain stimulators. Rising frequency of tremors and convenient FDA regulations for their treatment will help propel the market further.

Regional trends influencing neurostimulation devices industry growth:

  • China neurostimulation devices market is forecast to attain heavy gains at 18.0% over 2016-2023, driven by developing healthcare facilities and growing awareness regarding neurological disorders.
  • U.S. neurostimulation devices industry size was worth more than USD 2 billion in 2015 and is set to cross USD 5.5 billion by 2023, driven by high-tech medical infrastructure, excellent healthcare facilities, and growing patient awareness. Organizations such as the American Tinnitus Association and the North American Neuromodulation Society will help fuel regional growth.
  • Latin America neurostimulation devices market, dominated by Brazil and Mexico, contributed to around 4% of the overall share in 2015, and is likely to grow at a significant rate, which can be attributed to changing lifestyle, increasingly disposable incomes, developing healthcare facilities, and a huge number of patients.
  • Europe neurostimulation devices industry is set to register healthy gains, owing to contributing factors such as growing elderly population, government approval and encouragement, and rapid economic growth.

Neurostimulation devices market is segmented into products such as sacral nerve stimulator, gastric electric stimulator, deep brain stimulator, spinal cord stimulator, and vagus nerve stimulator.

Sacral nerve neurostimulation devices industry is expected to increase at a CAGR of more than 19% driven by the rising demand for incontinence products.

Spinal cord neurostimulation devices market is targeted to register around USD 6.5 billion by 2023, owing to the increasing recurrence of peripheral vascular disease, failed-back surgery syndrome, refractory angina pectoris, and complex regional pain syndrome.

Vagus nerve and gastric electric neurostimulation devices industry is anticipated to grow at a stable rate over 2016-2023.

Deep brain neurostimulation devices market is expected to depict profitable gains in the coming years and will grow at a CAGR of more than 17% over 2016-2023, driven by the requirement of treatment options for disorders such as dementia, depression, Parkinson’s, and obsessive compulsive disorders.

Key industry participants in this market include Cyberonics Inc., Nevro, Medtronic, Neuronetics, and Boston Scientific. Other vital companies are IntraPace, Codman & Shurtleff Inc., and St. Jude Medical. Companies are rigorously involved in R&D activities to develop sophisticated technologies and highly innovative products, owing to the fact that this industry is still nascent.

An ever-growing geriatric population falling prey to disorders such as Parkinson’s and Alzheimer’s will fuel product demand. The implementation of advanced technological developments such as transdermal neuromodulation technology and MRI safety-enabled devices to develop suitable treatment solutions for obesity, migraine, sleep apnea, and related ailments will contribute toward neurostimulation devices industry expansion.

Author NameSaipriya Iyer

Global X-Ray Photoelectron Spectroscopy market trends: Healthcare sector to display heavy growth potential

Posted on Updated on

Mounting need for analyzing surface chemistry of materials will drive X-Ray Photoelectron Spectroscopy (XPS) market size over the coming years. Escalating demand for XPS across pharmaceuticals, medical research, mining, chemical, and food sectors is expected to boost the industry trends. According to Global Market Insights, Inc., “Worldwide X-ray photoelectron spectroscopy market worth 475 million in 2015, is predicted to record a CAGR of 6% over the period of 2016 to 2023.” Growing requirement for detecting defects such as dewetting, craters, etc., along with the need to identify the problems during automotive coatings will further propel   the industry growth. Furthermore, favorable compensation policies, the presence of laboratories equipped with new technologies, and rising health awareness are other pivotal growth drivers of the industry.

U.S. X-ray Photoelectron Spectroscopy Market Size, By Application, 2012-2023 (USD Million)
U.S. X-ray Photoelectron Spectroscopy Market Size, By Application, 2012-2023 (USD Million)

X-ray photoelectron spectroscopy has noteworthy usages such as empirical formula determination, element detection, density estimation and contamination detection. X-ray photoelectron spectroscopy market in the contamination detection will exhibit fastest growth rate of more than 6% over the coming years of 2016 to 2023. The growth can be attributed to its surging demand across pharmaceutical, semiconductor, biotechnology, and electronics industries. Density estimation, element detection, and empirical formula determination will also contribute substantially towards the industry growth.

Get a Sample Copy of this Report:@ https://www.gminsights.com/request-sample/detail/431

Among the various notable applications such as bioengineering, automotive, electronics, semiconductor, aerospace, and healthcare of the X-ray photoelectron spectroscopy industry, healthcare application exhibited the eye-catching revenue and accounted for 40% of the global share in 2015. The escalating technological advancements and growing healthcare spending will further drive X-ray photoelectron spectroscopy industry size in the bioengineering sector.

X-ray photoelectron spectroscopy market size in the automotive sector will register an annual growth rate of 6.7% over the coming six years, primarily driven by its increasing use for finding defects and detecting contaminants.

Geographically, Asia Pacific X-ray photoelectron spectroscopy market share is anticipated to grow noticeably over the coming timeframe, owing to the developing infrastructure sector as well as expanding healthcare industry. China and India will be major revenue drivers for the APAC. India X-ray photoelectron spectroscopy industry will exhibit a growth rate of more than 8% over the coming years.

Supportive government rules & regulations as well as availability of fully developed laboratories will fuel the UK X-ray photoelectron spectroscopy industry size over the period of 2016 to 2023.

U.S. X-ray photoelectron spectroscopy industry share is projected to surpass revenue of USD 250 million by 2023. The surging installation of the instruments, which are incorporated with new innovative and enhanced technology are expected to fuel the regional demand growth. In addition, favorable government norms along with the implementation of FDA approved health policies regarding drug safety and quality will influence the X-ray photoelectron spectroscopy market noticeably.

Market giants are adopting various growth strategies like collaborations, mergers & acquisitions to maintain their business position across the globe. Intertek, Kett, Evans Analytical Group LLC, VG Scienta, Kratos Analytical Ltd, Yokogawa, Mitsubishi Electric, and Thermo Fisher Scientific are some of the noteworthy players in the X-ray photoelectron spectroscopy market.

Author NameSunil Hebbalkar

North America to lead the cell line development market landscape over 2016-2023

Posted on

Cell line development market is gaining massive business space in the industry due to the growing demand for biosimilars, novel drugs, and vaccines in the biotechnology industry. “Cell culture can be defined as the process by which cells are grown under controlled conditions, generally outside of their natural environment.” The development in research activities due to rising prevalence of cancer and auto immune disorders will create more need for cell lines, in turn fueling the global cell line development industry. According to Global Market Insights, Inc., “Cell Line Development Market size is anticipated to grow at a CAGR of 13% over the period of 2016-2023.” In addition to this, favorable government initiatives to improve healthcare set-up and the development of advanced technologies will subsequently surge the cell line development industry trends over the coming years.

UK Cell Line Development Market size, by Product, 2012-2023 (USD Million)

UK Cell Line Development Market size, by Product, 2012-2023 (USD Million)

This industry is analyzed based on products, source, cell line, geography, and applications. The cell line development market by product is segmented into three main types namely, reagents & media, equipment, and accessories & consumables. Reagents and media market share pegged at USD 1.5 billion in 2015 will continue to be the major product in the coming six years. Reagents & media are used in procedures including drug discovery, toxicity testing, regenerative medicines, and tissue engineering. Increasing usage of reagents & media in these measures will strengthen the product demand. Accessories and consumables market is likely to observe the highest annual growth rate of 16.3% from 2016-2023. The increasing usage rate of disposables in monoclonal antibodies and vaccines will in turn boost the cell line development industry. Equipment product segment is estimated to surpass USD 3 billion by 2023. This product segment accounted for 41.4% market share in 2015, and is expected to lose ground to the accessories and consumables market over the coming years.

Get a Sample Copy of this Report:@ https://www.gminsights.com/request-sample/detail/429

Mammalian and non-mammalian are the two types of sources in the cell line development industry. Within this, the non-mammalian is further classified into insects and amphibians. Mammalian cell line development dominated the market share in 2015 and is expected to exhibit similar trends, driven by the improved engineering and expression systems. Furthermore, the non-mammalian source market accounted for 25% of the industry share in 2015.

Based on cell line; recombinant, primary cell line, hybridomas, and continuous cell line are the four types in the cell line development industry. Among the four, recombinant cell line development market attained the highest industry share in 2015. Over the coming years, this market is probable to lose industry share to the hybridomas and primary cell line segments. Hybridoma cells accounted for the second highest market share in 2015. These cells are grown at larger density in culture flasks and roller bottles. Growing hybridoma cells culture, which can produce high density cultures over 15 to 25 times will in turn fuel the global cell line development industry growth.

Considering the global trends, North America led the global cell line development industry, owing to enhanced healthcare infrastructure, rinsing awareness regarding cell therapy, and increasing demand for biologics in the U.S. The U.S. cell line development market is projected to account for 85% market share over the period of 2016-2023.

Asia Pacific cell line development market is witnessing a significant growth due to existence of developing healthcare infrastructure, favorable government policies, rapid economic development. Significant investments by the global companies, mainly in India and China, will flourish the regional growth.

Latin America cell line development market is foreseen to register a CAGR of 13.3% over the period of 2016-2023. Brazil is another emerging market witnessing healthy growth in the cell line development industry.

Tissue engineering, research, drug discovery, bioproduction, and toxicity testing are the key application segments in the cell line development industry. Bioproduction application occupied the highest market value of USD 1306 million, shadowed by toxicity testing application market worth USD 598.3 million in 2015. The bioproduction is the leading application which is estimated to surpass USD 3 billion by 2023. The presence of advanced processes, introduction of biosimilars, and increase in R&D activities are the attributing factors in augmenting the overall segment growth.

The industry will witness intense competition and strategic initiatives to sustain the market position. The market is dominated by a limited number of players with better financial muscle thus providing threat to the new entrants in the industry. Notable companies operating in cell line development industry are Selexis American Type Culture Collection (ATCC), Thermo Fisher Scientific, GE Healthcare, Lonza Group, WuXi AppTec, European Collection of Cell Cultures (ECACC), Sigma-Aldrich Corporation, Sartorious, and Corning.

Author NameOjaswita Kutepatil